The nation of Zimbabwe has rejected a substantial American health deal valued at $367m (£272m) over five years due to the United States' insistence on confidential information.
The decision became public after a internal memorandum from December was leaked, which showed Head of State Emmerson Mnangagwa deemed the arrangement was "lopsided".
An official spokesperson later clarified that the US was demanding access to health data for scientific study and commercial purposes but was not willing to share the benefits from any future medical innovations.
"We are forced to start the difficult and regrettable task of scaling back our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the US had provided more than $1.9bn for health programmes to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has called for further talks to reach a agreement suitable to both sides so the nation's critical HIV treatment initiative can proceed.
Broader Background
Zimbabwe's decision comes after a similar case in Kenya, where a court halted a related health funding agreement after concerns were filed about the safety of citizens' health data.
Since resuming the presidency last year, US President Donald Trump has reduced foreign aid and closed the key foreign aid agency.
USAID had overseen assistance for the US government, but Trump claimed its expenditure was "wasteful" and his administration was seeking government-to-government agreements to enhance openness and responsibility.
According to reports, 16 nations in Africa have so far signed similar health pacts, representing more than $18.3bn in new funding.
Details of the Rejected Deal
The money for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this cooperation could have provided significant benefits for the people of Zimbabwe, especially the 1.2 million currently receiving HIV treatment through American-funded programmes," the Ambassador added.
However, government spokesperson Nick Mangwana maintained the arrangement was "asymmetrical".
"The proposal required Zimbabwe to provide its biological resources and data over an extended period, without any equivalent guarantee of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could be developed from that shared data," he stated.
"Put simply, our nation would provide the basic resources for medical research without any certainty that the resulting innovations would be available to our population if a future health crisis emerge."
National Interest and Global Health
He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral health agreements were upending systems previously established through the international organization.
Mangwana cited its Pathogen Access and Benefit Sharing system designed to manage future pandemics.
"This system is intended to ensure that when a nation contributes its information, the resulting advantages – such as vaccines and treatments – are shared equitably, not commercialised solely by those with the funds to create them."
Zimbabwe's reservations regarding the US deal "should not be misconstrued as opposition to America," he added.
"We are open to further dialogue with our US partners on how future collaboration might be structured in a manner that honours the sovereignty and interests of both nations."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the official position, but suggested that negotiations must proceed given that much of the nation's HIV programmes depended on external financing.
"If specific concerns exist, including those involving data governance or agreement terms, these can frequently be resolved through technical clarification and mutually agreed protections," it commented.
This impasse underscores the complex challenges between accepting crucial international aid and safeguarding local interests in an ever more data-driven world.